Ectopic ACTH syndrome of different origin-Diagnostic approach and clinical outcome. Experience of one Clinical Centre

PLoS One. 2020 Nov 25;15(11):e0242679. doi: 10.1371/journal.pone.0242679. eCollection 2020.

Abstract

Purpose: Ectopic Cushing Syndrome (EAS) is a rare condition responsible for about 5-20% of all Cushing syndrome cases. It increases the mortality of affected patients thus finding and removal of the ACTH-producing source allows for curing or reduction of symptoms and serum cortisol levels. The aim of this study is to present a 20-year experience in the diagnosis and clinical course of patients with EAS in a single Clinical Centre in Southern Poland as well as a comparison of clinical course and outcomes depending on the source of ectopic ACTH production-especially neuroendocrine tumors with other neoplasms.

Methods: Twenty-four patients were involved in the clinical study with EAS diagnosed at the Department of Endocrinology between years 2000 and 2018. The diagnosis of EAS was based on the clinical presentation, hypercortisolemia with high ACTH levels, high dose dexamethasone suppression test and/or corticotropin-releasing hormone tests. To find the source of ACTH various imaging studies were performed.

Results: Half of the patients were diagnosed with neuroendocrine tumors, whereby muscle weakness was the leading symptom. Typical cushingoid appearance was seen in merely a few patients, and weight loss was more common than weight gain. Patients with neuroendocrine tumors had significantly higher midnight cortisol levels than the rest of the group. Among patients with infections, we observed a significantly higher concentrations of cortisol 2400 levels in gastroenteropancreatic neuroendocrine tumors. Chromogranin A correlated significantly with potassium in patients with neuroendocrine tumors and there was a significant correlation between ACTH level and severity of hypokalemia.

Conclusion: EAS is not common, but if it occurs it increases the mortality of patients; therefore, it should be taken into consideration in the case of coexistence of severe hypokalemia with hypertension and muscle weakness, especially when weight loss occurs. Because the diagnosis of gastroenteropancreatic neuroendocrine tumor worsens the prognosis-special attention should be paid to these patients.

Publication types

  • Clinical Trial

MeSH terms

  • ACTH Syndrome, Ectopic* / blood
  • ACTH Syndrome, Ectopic* / diagnosis
  • ACTH Syndrome, Ectopic* / physiopathology
  • Adolescent
  • Adrenocorticotropic Hormone / blood
  • Adult
  • Aged
  • Cushing Syndrome / blood
  • Cushing Syndrome / diagnosis
  • Cushing Syndrome / physiopathology
  • Female
  • Humans
  • Hydrocortisone / blood
  • Hypertension / blood
  • Hypertension / diagnosis
  • Hypertension / physiopathology
  • Hypokalemia / blood
  • Hypokalemia / diagnosis
  • Hypokalemia / physiopathology
  • Male
  • Middle Aged
  • Muscle Weakness / blood
  • Muscle Weakness / diagnosis
  • Muscle Weakness / physiopathology
  • Poland
  • Retrospective Studies

Substances

  • Adrenocorticotropic Hormone
  • Hydrocortisone

Grants and funding

The authors received no specific funding for this work.